DNER and neoplasm: BET bromodomain inhibition as a monotherapy was relatively ineffective; however combined treated showed a trend towards increased anti-tumor activity as compared to either treatment alone early in treatment (Fig. 5a-b) as well as a potential survival benefit (Fig. 5c-d).